Structural Genomics Division, Saha Institute of Nuclear Physics, Kolkata, West Bengal, India.
Proteomics Clin Appl. 2011 Feb;5(1-2):98-108. doi: 10.1002/prca.201000063. Epub 2011 Jan 17.
Red blood cell proteome has not been studied well until recently, as the large abundance of hemoglobin posed challenge to the detection of other cytosolic proteins in the linear dynamic range. However, in the last couple of years, due to emergence of various novel hemoglobin depletion strategies and more state-of-the-art detection techniques, a number of works on erythrocyte proteome have appeared in the literature. As a result, we now have much deeper information about both the membrane as well as the cytosolic proteins of erythrocytes. In this review, we have discussed the role of red cell proteome on the two most well-studied hemoglobin disorders, sickle cell disease and thalassemia, emphasizing on the differential expression of the redox regulator proteins and chaperones, in particular. We have also touched upon the importance of the association of the varying levels of hemoglobin variants, particularly HbE on the clinical manifestation of composite diseases like HbEβ thalassemia.
直到最近,红细胞蛋白质组才得到充分研究,因为大量的血红蛋白给线性动态范围内其他胞质蛋白的检测带来了挑战。然而,在过去的几年中,由于各种新型血红蛋白去除策略和更先进的检测技术的出现,许多关于红细胞蛋白质组的工作已经在文献中出现。因此,我们现在对红细胞的膜蛋白和胞质蛋白有了更深入的了解。在这篇综述中,我们讨论了红细胞蛋白质组在两种研究最充分的血红蛋白疾病——镰状细胞病和地中海贫血——中的作用,特别强调了氧化还原调节剂蛋白和伴侣蛋白的差异表达。我们还探讨了血红蛋白变体(特别是 HbE)水平的变化与复合疾病(如 HbEβ 地中海贫血)临床表现之间的关联的重要性。